International Biotechnology Trust Stock Current Valuation
| IBT Stock | 652.00 2.00 0.31% |
Valuation analysis of International Biotechnology helps investors to measure International Biotechnology's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, International Biotechnology's Cash And Short Term Investments are projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 51.8 M, whereas Other Cashflows From Financing Activities is projected to grow to (10.9 M). Fundamental drivers impacting International Biotechnology's valuation include:
Price Book 0.8183 | Enterprise Value 250 M | Price Sales 6.2023 | Forward PE 714.2857 | Trailing PE 6.3922 |
Fairly Valued
Today
Please note that International Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of International Biotechnology is based on 3 months time horizon. Increasing International Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the International stock is determined by what a typical buyer is willing to pay for full or partial control of International Biotechnology Trust. Since International Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of International Stock. However, International Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 652.0 | Real 666.64 | Hype 652.56 | Naive 669.64 |
The real value of International Stock, also known as its intrinsic value, is the underlying worth of International Biotechnology Company, which is reflected in its stock price. It is based on International Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of International Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of International Biotechnology Trust helps investors to forecast how International stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of International Biotechnology more accurately as focusing exclusively on International Biotechnology's fundamentals will not take into account other important factors: International Biotechnology Trust Company Current Valuation Analysis
International Biotechnology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current International Biotechnology Current Valuation | 250.04 M |
Most of International Biotechnology's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, International Biotechnology Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, International Biotechnology Trust has a Current Valuation of 250.04 M. This is 99.24% lower than that of the Capital Markets sector and 96.66% lower than that of the Financials industry. The current valuation for all United Kingdom stocks is 98.5% higher than that of the company.
International Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses International Biotechnology's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of International Biotechnology could also be used in its relative valuation, which is a method of valuing International Biotechnology by comparing valuation metrics of similar companies.International Biotechnology is currently under evaluation in current valuation category among its peers.
International Biotechnology ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, International Biotechnology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to International Biotechnology's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
International Fundamentals
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0806 | ||||
| Profit Margin | 0.91 % | ||||
| Operating Margin | 1.00 % | ||||
| Current Valuation | 250.04 M | ||||
| Shares Outstanding | 35.42 M | ||||
| Shares Owned By Insiders | 1.42 % | ||||
| Shares Owned By Institutions | 27.32 % | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 6.20 X | ||||
| Revenue | 40.14 M | ||||
| Gross Profit | 42.88 M | ||||
| EBITDA | 39.55 M | ||||
| Net Income | 38.88 M | ||||
| Total Debt | 22.83 M | ||||
| Book Value Per Share | 7.66 X | ||||
| Cash Flow From Operations | 45.35 M | ||||
| Earnings Per Share | 1.02 X | ||||
| Beta | 0.18 | ||||
| Market Capitalization | 230.96 M | ||||
| Total Asset | 308.15 M | ||||
| Retained Earnings | (54.03 M) | ||||
| Annual Yield | 0.05 % | ||||
| Net Asset | 308.15 M | ||||
| Last Dividend Paid | 0.28 |
About International Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze International Biotechnology Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of International Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of International Biotechnology Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in International Stock
International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.